GlaxoSmithKline places its shingles vaccine ... shot in all territories other than BioNTech's home market of Germany, Turkey and certain other developing countries. "Adults aged 50 years and ...

Visitors to Columbia’s antique shops, river trail and Turkey Hill Experience will no longer have to leave town to find a ...

Wheeler's currently playing for the Nesibe Aydin GSK in the Women’s Basketball Super League in Turkey. She's averaging 14.4 points, 4.6 rebounds and 6.7 assists per game there. The Storm will be ...

Astellas also has rights to the drug in Japan – where it also approved and on sale – as well as Turkey, Russia ... has provided an opportunity for GSK and Akebia to beat FibroGen and AZ ...

Wheeler currently plays on Nesibe Aydin GSK in the Women’s Basketball Super League in Turkey. Storm Season Tickets, Mini and Flex Plans, and Group Experiences are available for the 2025 season ...

It has been about a month since the last earnings report for GSK (GSK). Shares have added about 8% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up ...

The market was pleased with the recent earnings report from GSK plc (LON:GSK), despite the profit numbers being soft. However, we think the company is showing some signs that things are more ...

LONDON, - British drugmaker GSK will no longer set diversity targets, it said on Thursday, as it became the latest company to scale back or abandon such goals in response to the U.S. president's ...

Bernstein analyst Florent Cespedes maintained a Buy rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £22.90. The company’s shares opened today at p1,443. ...

It has been about a month since the last earnings report for GSK (GSK). Shares have added about 8% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up to ...